Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 Total Liabilities

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 (HROWL) currently reports a total liabilities of $400M as of June 2026. That compares with $300M in the prior-year period — up 35.9% year over year. Use the charts on this page to explore Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's total liabilities history and peer comparisons.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's total liabilities increased from $300M to $400M — a 35.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 reported $400M in total liabilities as of June 2026. That compares with $300M in the prior-year period — up 35.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $400M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Harrow- 8.625% NT REDEEM 30/04/2026 USD 25, and consider following HROWL for alerts when major investors trade the stock.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 is classified in the Healthcare sector. On total liabilities, it currently shows $400M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HROWL with unrelated industries.